Lyell Immunopharma Reports $38.8M Loss in Q3
Update: 2025-11-12
Description
Lyell Immunopharma reports significant third-quarter loss, with a net loss of $38.8 million and a loss of $2.13 per share. Revenue stands at a modest $15,000. The companys performance will be closely monitored as they navigate the biotechnology sector.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
